Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,255.40
+11.000.88%
Post-market: 1,254.06-1.3400-0.11%19:59 EDT
Volume:2.50M
Turnover:3.14B
Market Cap:1.19T
PE:42.14
High:1,271.22
Open:1,232.00
Low:1,230.00
Close:1,244.40
52wk High:1,292.65
52wk Low:694.23
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.91
T/O Rate:0.27%
Dividend:6.46
Dividend Rate:0.51%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:35.03
PE(LYR):54.70

Loading ...

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Movement Alert|Eli Lilly Rises 3.02% in Regular Trading, Oral GLP-1 Drug Gains First European Approval in UK

Market Focus
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Eli Lilly and Company Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Aug 08

Form 144 | ELI LILLY Officer Hakim proposes to sell 10000 Shares, with a total value of approximately $11.9 Million.

Filings Track
·
Aug 07

Mediar Therapeutics Signs Collaboration, Option Deal with Ono Pharma on Fibro-Inflammatory Disease Antibodies

Reuters
·
Aug 07

Eli Lilly : Truist Securities Raises Target Price to $1376 from $1370

THOMSON REUTERS
·
Aug 07

Morning BID Americas-Dealjà Vu

Reuters
·
Aug 07

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07

8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman

Bloomberg
·
Aug 07

Eli Lilly's Incretin Performance Supports Long-Term Growth, Truist Says

MT Newswires Live
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Eli Lilly Outperformance and Incretin Momentum Support Buy Rating with Unchanged $1,385 Price Target

TIPRANKS
·
Aug 06

Rumors Swirl That Eli Lilly (LLY) Will Split Its Stock After Blockbuster Earnings

TIPRANKS
·
Aug 06